1st Quarter - Report

HANCE SCARBOROUGH for ALLIANCE FOR PHARMACY COMPOUNDING

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations. HR167, the Patient Access to Urgent Use Compounded Medication Act

LobbyistCovered position, as disclosed
ROBERT DAVID PORE Legislative Director, Cong. Jim Turner
THERESA REED Leg. Director for Multiple Members
MICHAEL TOMBERLIN Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep., Louie Gohmert

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 167 (119th)

Pharmacy PHA

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations. HR167, the Patient Access to Urgent Use Compounded Medication Act

LobbyistCovered position, as disclosed
ROBERT DAVID PORE Legislative Director, Cong. Jim Turner
THERESA REED Leg. Director for Multiple Members
MICHAEL TOMBERLIN Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep. Louie Gohmert

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 167 (119th)

Budget/Appropriations BUD

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations. HR167, the Patient Access to Urgent Use Compounded Medication Act

LobbyistCovered position, as disclosed
ROBERT DAVID PORE Leg. Director for Cong. Jim Turner
THERESA REED Leg. Director for Multiple Members
MICHAEL TOMBERLIN COS for Rep. Chip Cravaack, COS for Rep. Louie Gohmert

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 167 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.